Journal
CELL DEATH & DISEASE
Volume 10, Issue -, Pages -Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/s41419-018-1295-1
Keywords
-
Categories
Funding
- European Union's Seventh Framework Programme for Research, Technological Development and Demonstration [600841]
- Deutsche Forschungsgemeinschaft [SFB 894]
- Michael J. Fox foundation
Ask authors/readers for more resources
NF-kappa B functions as modulator of T cell receptor-mediated signaling and transcriptional regulator of miR-34a. Our in silico analysis revealed that miR-34a impacts the NF-kappa B signalosome with miR-34a binding sites in 14 key members of the NF-kappa B signaling pathway. Functional analysis identified five target genes of miR-34a including PLCG1, CD3E, PIK3CB, TAB2, and NFKBIA. Overexpression of miR-34a in CD4(+) and CD8(+) T cells led to a significant decrease of NFKBIA as the most downstream cytoplasmic NF-kappa B member, a reduced cell surface abundance of TCRA and CD3E, and to a reduction of T cell killing capacity. Inhibition of miR-34a caused an increase of NFKBIA, TCRA, and CD3E. Notably, activation of CD4(+) and CD8(+) T cells entrails a gradual increase of miR-34a. Our results lend further support to a model with miR-34a as a central NF-kappa B regulator in T cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available